NEUROCUTANEOUS SYNDROMES
(NF-1, NF-2, Sturge–weber syndrome)
Neurocutaneous syndromes(Phakomatoses)
• These are group of heterogeneous disorders
involving the structures derived from the
embryonic neuroectoderm- the central
nervous system, eyes and skin.
• The syndromes are characterized by
distinctive CNS, cutaneous , ocular and
oncological manifestations .
• usually present in childhood, with new
manifestations occurring over lifetime
Common syndromes :
• Neurofibromatosis type I.
• Neurofibromatosis type 2.
• Sturge – weber syndrome.
• Von hippel – lindau disease.
• Tuberous sclerosis.
• Neurofibromatoses (NFs) are a subgroup of
phakomatoses and are classified into three
types:
1)NF1 or peripheral neurofibromatosis,
2)NF2 or central neurofibromatosis
3)Schwannomatosis
Neurofibromatosis type 1
• It is the most common neurocutaneous
syndrome.
• von Recklinghausen disease
• It is an autosomal dominant condition
• Characterized by neoplastic and nonneoplastic
involvement of skin, eye, bone, endocrine and
central nervous system.
Genetics :
Chr 17q11.2 – Tumour suppressor gene (NF1
gene , Neurofibromin protein)
(Germ line mutation)
Loss of tumour supressor function
Abnormal , uncontrolled proliferation of these
cells (neurons , glial cells , schwann cells)
Hyperplasia , hamartomas , neoplasms (Bening
and malignant)
Clinical features
• Café au lait macules
• Lisch nodules
• Neurofibromas
• Axillary / inguinal freckling
Café au lait macules:
• Oval or round,
• hyperpigmented spots
• Smooth borders
• May be seen at birth.
• "coast of California" pattern
McCune–Albright syndrome
"coast of Maine" pattern.
Freckling :
• Freckles are brown macules of 1–3 mm size.
• Location: axillary, inguinal, sub mammary and
neck regions.
• Appear by 4-5 yrs of age even before
cutaneous neurofibromas.
Lisch nodules :
• These are melanocytic hamartomas of iris .
• Appears as small, dome-shaped hyper
pigmented macules.
• Do not cause functional impairment of vision.
Neurofibromas
 These are one of the hallmarks of NF1.
 Bening peripheral nerve sheath tumors.
Based on location they are :
• Cutaneous
• Subcutaneous
Cutaneous neurofibromas:
Appears at puberty.
Size : mm-cm
Skin colored to brown.
Polypoidal / pedunculated soft lesions.
Classical button hole sign.
Subcutaneous NF:
• Firm and nodular lesions
From dorsal root ganglion – Dumb bell shaped
tumours.
• In neck – beaded neckalce pattern(mimicking
lymphadenitis.)
Based on morphology NFs are :
• Localized
• Diffuse
• Plexiform.
• MPNSTs.
Localized NFs:
• Most common type of neurofibroma in NF1
pateints.
• They can be sporadic (involve superficial
cutaneous nerves) , NF1 associated(tend to
involve deep nerves , multiple , large).
On CT :
• well-defined, soft-tissue mass, hypodense to
muscle and showing little or no enhancement
with contrast.
On MRI :
• T1W : Low to intermediate signal intensity .
• T2W images : homogeneous high signal
intensity.
Specific signs for neurogenic tumors
• Target sign
• Reverse target sign
• Split fat sign
• Fascicular sign
• Nerve entering or exiting the lesion.
• Muscle atrophy in nerve distribution.
T2W – Hypointense center – fibrocollagenous core.
Hyperintense periphery – myxoid tissue
Split fat sign:
Fat around periphery of lesion more pronounced
at the proximal and distal ends.
Not specific for neurogenic tumors.
But confirms intramuscular location.
Absent in MPNSTs.
• Neurofibromas and schwannomas : fusiform,
circumscribed soft-tissue masses.
• Neurofibroma appears centred on
and indistinctive from nerve.
schwannoma - eccentrically to the nerve.
• Neurofibromas- homogeneous lesions .
Schwannomas - heterogeneous
appearance with cystic,
necrotic and calcific areas.
Diffuse neurofibroma –
Most common among children and young adults, typically involving the skin
and subcutaneous tissues of the head and neck , may extend to the
underlying fascia and muscles.
These are poorly defined , that spreads along connective tissue septa and
surrounds rather than destroys adjacent normal structures
Four morphological patterns on imaging:
• Plaque-like lesions
• Infiltrative lesions
• Mass-like lesions
• Mixed pattern.
Diffuse neurofibroma has a very low probability of malignant
transformation (Surgical excision is not mandatory)
Plaque like NF:
• Patch of abnormal tissue without intervening
normal tissue.
• show prominent internal vascularity
Infiltrative Diffuse NF:
Ill defined lesions with interspersed normal
tissue.
Mass-like lesions:
Well defined margins
Plexiform neurofibroma
• It is unique and pathognomic to NF1.
• PN present in childhood before cutaneous NFs.
• Significant risk of malignant transformation - 5%–10%.
• Involves multiple branches of large nerves, growing along their
length and causing
-expansion of the nerves
-extend beyond epineurium into surrounding tissues
-Marked disfigurement
-compression of vital structures
-progressive neurological deficit
-pain.
Plexiform neurofibroma :
• Classical bag of worms
• Scrotum without testicle
• Hyperpigmented and
hypertrichosis of overlying
skin.
On CT:
• Large, hypodense, infiltrative lesions
• No significant contrast enhancement and
cause erosion of adjacent bones.
On MRI
• Multinodular coalescent lesions
• T1W images - hypointense
• T2W images - heterogeneously hyperintense
with multiple target signs
• variable contrast enhancement.
• Rapid growth and atypical pain in a PN are
alarming signs for malignant transformation.
• Elephantiasis neuromatosa - PN occurring in
an extremity causing gigantic enlargement
with substantial disfigurement
Malignant peripheral nerve sheath tumour
• Preexisting plexiform neurofibroma
• Tend to involve larger nerve trunks such as
sacral plexus, brachial plexus and sciatic nerve.
Signs of malignant transformation-
• Sudden increase in size
• worsening pain
• Neurological symptoms
• MPNSTs – Sporadic (>60 yrs) ,
NF1associated(15-40yrs)
• These are high grade sarcomas with poor
prognosis.
• Complete surgical excision followed by
chemoradiotherapy is the treatment of choice
MPNSTs –
• Fusiform masses with heterogeneous
appearance (haemorrhagic and necrotic
components).
• Size > 5 cm.
• Irregular margins due to infiltration of adjacent
tissues.
• Perilesional edema
• Heterogeneous enhancement (peripheral
nodular enhancement ).
• 10-15% are FDG PET +.
Skeletal manifestations
• These are one among most frequent
manifestation of NF1 with incidence of 25-
40%.
 Dysplasia of tibia and other long bones.
 Vertebral and spinal manifestations.
 Sphenoid wing dysplasia.
 Multiple NOF’s.
 Other skeletal manifestations.
• Dysplasia of tibia and other long bones
Vertebral deformities
• Scoliosis - most common skeletal
manifestation of NF1
• Commonly involves the thoracic region.
• These are generally classified into non-
dystrophic and dystrophic types based on the
absence or presence of skeletal dysplasia on
plain radiographic evaluation.
Dysplastic features
• vertebral scalloping ( depth of scalloping is more
than 3 mm in thoracic and 4 mm in lumbar
vertebrae ),
• Rib pencilling (width of the involved rib < narrowest
portion of second rib),
• wedging of the vertebra,
• Paraspinal or intraspinal soft-tissue masses,
• Intervertebral foramina enlargement,
• Dysplastic pedicles and interpedicular distance
widening.
• This dysplastic features occurs due to - congenital
osteopathy of vertebrae .Dural ectasia and spinal
neurofibromas may contribute to its progression.
• Non dystrophic scoliosis – more common , ~
adolescent idiopathic scoliosis.
• Dystrophic scoliosis – short segment (4-6 vertebral
levels) , sharply angulated , associated with kyphosis.
• Dystrophic curves should be further evaluated with
whole spine MRI to assess intraspinal mass lesions,
especially when surgery is planned.
• Dystrophic scoliosis has a progressive course
demanding aggressive surgical treatment
• Dural ectasia is another spinal manifestation
of NF1 resulting from expansion of the thecal
sac and spinal nerve root sleeve, causing
posterior vertebral scalloping and lateral
thoracic meningocele formation.
• Dural ectasia may cause vertebral
instability with subluxations and
dislocations.
Spinal canal lesions
• IDEM NF’s are common lesions ,
foraminal/extraforaminal neurofibromas. They
can cause scalloping of vertebrae and
widening of neural foramina.
• IM lesions - astrocytomas .
Sphenoid wing dysplasia
• Sphenoid wing dysplasia is seen in approximately 11% of
NF1 patients
• It is almost always unilateral causing orbital asymmetry.
• It is characterized by hypoplasia of greater wing of sphenoid
bone with enlargement of the middle cranial fossa.
• Herniation of dura, CSF spaces or anterior temporal lobe
into posterior aspect of orbit and anterior temporal
arachnoid cysts are often seen.
• Bare orbit sign is a classical radiographic finding of NF1.
• It describes the absence of innominate line on the frontal
radiograph of the skull, which is formed by the greater wing
of sphenoid bone.
CNS manifestations
Neoplastic lesions:
• Optic pathway glioma (OPG)
• Nonoptic gliomas
Optic pathway glioma (OPG)
• OPG is the most common CNS neoplasm in paediatric patients.
• The presence of bilateral optic nerve gliomas (ONG) is considered
pathognomonic for NF1.N
The main radiologic criteria to diagnose ONG are
• Thickened optic nerve(>3.9 mm )
• With or without prominence of perioptic CSF spaces.
• They show interrupted ‘dotted i’ appearance on axial images
• Beanshaped kinky appearance in coronal images .
• The optic canal may be widened with bony remodelling and
scalloping.
• The lesions may extend along optic pathway to the optic chiasm, the
optic tracts and optic radiations.
Nonoptic gliomas :
• They are commonly seen in cerebellum,
brainstem, tectal plate and basal ganglia
regions.
• The vast majority are low-grade gliomas
mainly pilocytic astrocytomas;
Benign nonneoplastic lesions
Foci of altered signal intensity(FASI’s or UBO’s) :
• Hamartomatous lesions of white matter, involve basal
ganglia, thalami, dentate nuclei, cerebellar peduncles,
optic radiations and brainstem in children and adolescents.
• Represent regions of myelin vacuolization.
• They are hyperintense on T2 sequences and typically iso-
to mildly hyperintense on T1 images.
• They do not show mass effect or enhancement unlike low-
grade gliomas which show mass effect and sometimes
enhancement.
Cardiac and vascular manifestations
• NF1 vasculopathy is one of the leading causes of death
in NF1 patients.
• Renal artery stenosis with renovascular hypertension is
the most frequent presentation, usually in the second
decade of life.
• Aneurysms and stenoses of aortic, renal, mesenteric
and intracranial vasculature - younger patients.
• Degenerative atherosclerotic aneurysm of the aorta -
older patients.
• Abnormalities of cerebral vasculature –”moyamoya”
pattern.
Thoracic manifestations
• Neurofibromas at different locations
• Interstitial lung disease, late onset complication
- cysts or bullae
- upper lobe
- diffuse ground-glass opacities with mosaic pattern
and bibasilar reticular opacities.
• Neurofibromas involving trachea and oesophagus
have also been reported.
Abdominal manifestations
• Broad spectrum of benign and malignant
neoplasms.
• Most frequent – neurofibroma , plexiform
type .
• Location - Paraspinal and presacral region ,
mesentery, gastrointestinal tract, liver and
biliary tract, urinary bladder.
• In GIT - GISTs are most common , multifocal ,
small bowel.
Breast manifestations
• Multiple subcutaneous neurofibromas in
periareolarregion.
• On mammo- multiple, circumscribed and may
be surrounded by a rim of air owing to their
superficial nature.
• On USG- similar to fibroadenomas in the
subcutaneous plane.
• NF1 is also associated with an increased risk of
breast cancer development.
Orbital manifestations
• Orbital–periorbital plexiform neurofibroma
(OPPN) - Plexiform neurofibroma involving the
orbit, eyelid, periorbital and facial structures
and usually arise from the trigeminal nerve.
• It is associated with sphenoid wing dysplasia
on the same side.
• OPPN is seen as poorly defined infiltrative
lesion of the orbit and may extend to involve
face and cranium.
Neurofibromatosis 2
• Less common than NF1.
• Characterized by multiple cranial nerve
schwannomas, meningiomas and spinal
tumours.
• It is considered synonymous with bilateral
acoustic schwannomas.
GENETICS:
• Autosomal dominant inheritance.
• Chr.22
• NF2 gene
• Merlin protien(regulates growth of schwann
cells and arachnoid cap cells)
Clinical manifestations:
• Hearing loss, tinnitus, headache followed by
diplopia, vertigo, dizziness, imbalance and
facial weakness.
• Other presentations are neuropathies,
scoliosis, paraplegia or neck pain, extremity
weakness and cataract.
Cutaneous manifestations:
• CALMs – Few , no freckles.
• Cutaneous schwannomas – slightly raised ,
plaque like , pigmented lesions.
Central nervous system:
• Cranial nerve schwannomas- 8th
nerve ,MC.
• Meningiomas
• Meningioangiomatosis.
• Glial hamartomas.
Schwannomas:
The characteristic imaging features include
• well-defined, encapsulated lesions
• with or without cystic degeneration and
haemorrhage.
• well-circumscribed margins.
• Smooth expansion of osseous foramina, osseous
remodelling .
• Deformation of adjacent brain parenchymal tissue.
• Various degrees of solid nodular enhancement
with internal cystic degeneration.
• T1W : Isointense to muscle.
• T2W : Heterogenously hyperintense.
• T1+C : Heterogenous moderate to intense
enhancement (cystic / necrotic areas)
Meningiomas.
• Meningiomas are second most common type
of lesions in neurofibromatosis 2.
• Meningiomas can be seen in the cranial and
spinal regions.
• Meningioma in first decade of life is highly
suspicious of NF2.
Spinal tumours:
• IM - Ependymomas are the most common.
These tumours cause focal cord enlargement
and may be associated with proximal syrinx.
• IDEM - Schwannomas of exiting nerve roots,
spinal meningiomas.
• MISME, which constitute multiple inherited
schwannomas, meningiomas and
ependymomas.
Ophthalmic manifestations:
• Optic nerve sheath meningioma.
• Juvenile posterior subcapsular cataract.
• Retinal hamartomas.
Optic nerve sheath meningioma:
• Sporadic (adults), NF2 associated(children).
• Arise from arachnoid cap cells of optic sheath.
• Visual loss – due to compression on optic nerve.
• Axial MRI – Tramtrack sign , Coronal MRI –
Doughnut sign.
• Calcifications +.
• Hyperostosis of adjacent bones may be seen.
SCHWANNOMATOSIS
• Multiple schwannomas without vestibular or
cutaneous schwannomas.
• Mutation in LZTR1 and SMARCB1 gene on
Chr.22.
• Pain is most common symptom.
• >3rd
– 6th
decade .
Sturge–Weber syndrome
• Sturge–Weber syndrome (SWS) is also known
as encephalo-trigeminal angiomatosis.
• Vascular and cutaneous features predominate
without neoplasms.
Genetics:
• Sporadic mutation of GNAQ gene located on
Chr.9q21.
• Lack of maturation of primordial thin walled
vessels Abnormal capillary and venous
channels seen over leptomeninges ,
face , eye as Angiomas longstanding –
venous ischemia.
Clinical presentation:
• Seizures in infancy
• Glaucoma.
• Hemiparesis
• Hormonal deficiencies,other vascular
malformations are also known in SWS.
Neuroimaging in Sturge–Weber syndrome
On CT scan- dystrophic cortical and subcortical
calcifications - tram track gyriform calcification.
-U/L – 80%.
-MC location – parietooccipital region.
• Focal cerebral atrophy .
• Thickened skull vault.
• Ipsilateral choroid plexus enlargment.
• Ipsilateral PNS and mastoid air cells dilated.
MRI:
• Ipsilateral cerebral atrophy.
• Enlargement of subarchnoid spaces.
• Calcifications – T2 – Hypo, GRE – blooming.
• T1+C – intense leptomeningeal enhancement.
• MRS – Reduced NAA.
OPTHALMIC MANIFESTATIONS:
• Choroid angiomas – Crescentric thickening of
posterior wall of globe.
• T1 : Hyper , T2 : Iso , T1+C : Intense
enhancement.
• Glaucoma.
• Visual disturbance.
• Buphthalmos.
Cutaneous manifestations:
• Port wine stain – capillary vascular malformation
in face along the divisions of trigeminal nerve
(ophthalmic division is most commonly involved
– fore head and upper eye lid).
• Focal soft tissue mass in skin and subcutaneous
plane.
CT : Iso – hypo to muscle.
T1W : Iso – hypo
T2W : Hyper
Post contrast – intense enhancement.
DD’s:
• Acquired meningeal processes – Meningitis ,
tumour spread , hemorrhage.
• Meningioangiomatosis – It is rare
meningovascular hamartomatous plaque like
mass .No PWS.
• Klippel–trenaunay–webersynd : pial angiomas
present associated soft tissue and bone
hypertrophy.
• PHACES syndrome(posterior fossa malformations ,
infantile hemangiomas , arterial anamolies ,
coarctation of aorta , cardiac , eye and sternal
anamolies ).
THANK YOU
• Tommorow case presentations by Dr . Reshma
(HRCT temporal bone anatomy) and Dr . Avani
(Pylonephritis)

NEUROCUTANEOUS SYNDROMES NF-1, NF-2, Sturge–weber syndrome.pptx

  • 1.
    NEUROCUTANEOUS SYNDROMES (NF-1, NF-2,Sturge–weber syndrome)
  • 2.
    Neurocutaneous syndromes(Phakomatoses) • Theseare group of heterogeneous disorders involving the structures derived from the embryonic neuroectoderm- the central nervous system, eyes and skin. • The syndromes are characterized by distinctive CNS, cutaneous , ocular and oncological manifestations . • usually present in childhood, with new manifestations occurring over lifetime
  • 3.
    Common syndromes : •Neurofibromatosis type I. • Neurofibromatosis type 2. • Sturge – weber syndrome. • Von hippel – lindau disease. • Tuberous sclerosis.
  • 4.
    • Neurofibromatoses (NFs)are a subgroup of phakomatoses and are classified into three types: 1)NF1 or peripheral neurofibromatosis, 2)NF2 or central neurofibromatosis 3)Schwannomatosis
  • 5.
    Neurofibromatosis type 1 •It is the most common neurocutaneous syndrome. • von Recklinghausen disease • It is an autosomal dominant condition • Characterized by neoplastic and nonneoplastic involvement of skin, eye, bone, endocrine and central nervous system.
  • 6.
    Genetics : Chr 17q11.2– Tumour suppressor gene (NF1 gene , Neurofibromin protein) (Germ line mutation) Loss of tumour supressor function Abnormal , uncontrolled proliferation of these cells (neurons , glial cells , schwann cells) Hyperplasia , hamartomas , neoplasms (Bening and malignant)
  • 7.
    Clinical features • Caféau lait macules • Lisch nodules • Neurofibromas • Axillary / inguinal freckling
  • 8.
    Café au laitmacules: • Oval or round, • hyperpigmented spots • Smooth borders • May be seen at birth. • "coast of California" pattern McCune–Albright syndrome "coast of Maine" pattern.
  • 9.
    Freckling : • Frecklesare brown macules of 1–3 mm size. • Location: axillary, inguinal, sub mammary and neck regions. • Appear by 4-5 yrs of age even before cutaneous neurofibromas.
  • 10.
    Lisch nodules : •These are melanocytic hamartomas of iris . • Appears as small, dome-shaped hyper pigmented macules. • Do not cause functional impairment of vision.
  • 11.
    Neurofibromas  These areone of the hallmarks of NF1.  Bening peripheral nerve sheath tumors. Based on location they are : • Cutaneous • Subcutaneous
  • 12.
    Cutaneous neurofibromas: Appears atpuberty. Size : mm-cm Skin colored to brown. Polypoidal / pedunculated soft lesions. Classical button hole sign.
  • 13.
    Subcutaneous NF: • Firmand nodular lesions From dorsal root ganglion – Dumb bell shaped tumours. • In neck – beaded neckalce pattern(mimicking lymphadenitis.)
  • 15.
    Based on morphologyNFs are : • Localized • Diffuse • Plexiform. • MPNSTs.
  • 16.
    Localized NFs: • Mostcommon type of neurofibroma in NF1 pateints. • They can be sporadic (involve superficial cutaneous nerves) , NF1 associated(tend to involve deep nerves , multiple , large).
  • 17.
    On CT : •well-defined, soft-tissue mass, hypodense to muscle and showing little or no enhancement with contrast.
  • 18.
    On MRI : •T1W : Low to intermediate signal intensity . • T2W images : homogeneous high signal intensity.
  • 19.
    Specific signs forneurogenic tumors • Target sign • Reverse target sign • Split fat sign • Fascicular sign • Nerve entering or exiting the lesion. • Muscle atrophy in nerve distribution.
  • 20.
    T2W – Hypointensecenter – fibrocollagenous core. Hyperintense periphery – myxoid tissue
  • 21.
    Split fat sign: Fataround periphery of lesion more pronounced at the proximal and distal ends. Not specific for neurogenic tumors. But confirms intramuscular location. Absent in MPNSTs.
  • 23.
    • Neurofibromas andschwannomas : fusiform, circumscribed soft-tissue masses. • Neurofibroma appears centred on and indistinctive from nerve. schwannoma - eccentrically to the nerve. • Neurofibromas- homogeneous lesions . Schwannomas - heterogeneous appearance with cystic, necrotic and calcific areas.
  • 24.
    Diffuse neurofibroma – Mostcommon among children and young adults, typically involving the skin and subcutaneous tissues of the head and neck , may extend to the underlying fascia and muscles. These are poorly defined , that spreads along connective tissue septa and surrounds rather than destroys adjacent normal structures Four morphological patterns on imaging: • Plaque-like lesions • Infiltrative lesions • Mass-like lesions • Mixed pattern. Diffuse neurofibroma has a very low probability of malignant transformation (Surgical excision is not mandatory)
  • 25.
    Plaque like NF: •Patch of abnormal tissue without intervening normal tissue. • show prominent internal vascularity
  • 26.
    Infiltrative Diffuse NF: Illdefined lesions with interspersed normal tissue.
  • 27.
  • 28.
    Plexiform neurofibroma • Itis unique and pathognomic to NF1. • PN present in childhood before cutaneous NFs. • Significant risk of malignant transformation - 5%–10%. • Involves multiple branches of large nerves, growing along their length and causing -expansion of the nerves -extend beyond epineurium into surrounding tissues -Marked disfigurement -compression of vital structures -progressive neurological deficit -pain.
  • 29.
    Plexiform neurofibroma : •Classical bag of worms • Scrotum without testicle • Hyperpigmented and hypertrichosis of overlying skin.
  • 30.
    On CT: • Large,hypodense, infiltrative lesions • No significant contrast enhancement and cause erosion of adjacent bones. On MRI • Multinodular coalescent lesions • T1W images - hypointense • T2W images - heterogeneously hyperintense with multiple target signs • variable contrast enhancement.
  • 33.
    • Rapid growthand atypical pain in a PN are alarming signs for malignant transformation. • Elephantiasis neuromatosa - PN occurring in an extremity causing gigantic enlargement with substantial disfigurement
  • 34.
    Malignant peripheral nervesheath tumour • Preexisting plexiform neurofibroma • Tend to involve larger nerve trunks such as sacral plexus, brachial plexus and sciatic nerve. Signs of malignant transformation- • Sudden increase in size • worsening pain • Neurological symptoms
  • 35.
    • MPNSTs –Sporadic (>60 yrs) , NF1associated(15-40yrs) • These are high grade sarcomas with poor prognosis. • Complete surgical excision followed by chemoradiotherapy is the treatment of choice
  • 36.
    MPNSTs – • Fusiformmasses with heterogeneous appearance (haemorrhagic and necrotic components). • Size > 5 cm. • Irregular margins due to infiltration of adjacent tissues. • Perilesional edema • Heterogeneous enhancement (peripheral nodular enhancement ). • 10-15% are FDG PET +.
  • 39.
    Skeletal manifestations • Theseare one among most frequent manifestation of NF1 with incidence of 25- 40%.  Dysplasia of tibia and other long bones.  Vertebral and spinal manifestations.  Sphenoid wing dysplasia.  Multiple NOF’s.  Other skeletal manifestations.
  • 40.
    • Dysplasia oftibia and other long bones
  • 41.
    Vertebral deformities • Scoliosis- most common skeletal manifestation of NF1 • Commonly involves the thoracic region. • These are generally classified into non- dystrophic and dystrophic types based on the absence or presence of skeletal dysplasia on plain radiographic evaluation.
  • 42.
    Dysplastic features • vertebralscalloping ( depth of scalloping is more than 3 mm in thoracic and 4 mm in lumbar vertebrae ), • Rib pencilling (width of the involved rib < narrowest portion of second rib), • wedging of the vertebra, • Paraspinal or intraspinal soft-tissue masses, • Intervertebral foramina enlargement, • Dysplastic pedicles and interpedicular distance widening.
  • 43.
    • This dysplasticfeatures occurs due to - congenital osteopathy of vertebrae .Dural ectasia and spinal neurofibromas may contribute to its progression. • Non dystrophic scoliosis – more common , ~ adolescent idiopathic scoliosis. • Dystrophic scoliosis – short segment (4-6 vertebral levels) , sharply angulated , associated with kyphosis. • Dystrophic curves should be further evaluated with whole spine MRI to assess intraspinal mass lesions, especially when surgery is planned. • Dystrophic scoliosis has a progressive course demanding aggressive surgical treatment
  • 44.
    • Dural ectasiais another spinal manifestation of NF1 resulting from expansion of the thecal sac and spinal nerve root sleeve, causing posterior vertebral scalloping and lateral thoracic meningocele formation. • Dural ectasia may cause vertebral instability with subluxations and dislocations.
  • 46.
    Spinal canal lesions •IDEM NF’s are common lesions , foraminal/extraforaminal neurofibromas. They can cause scalloping of vertebrae and widening of neural foramina. • IM lesions - astrocytomas .
  • 47.
    Sphenoid wing dysplasia •Sphenoid wing dysplasia is seen in approximately 11% of NF1 patients • It is almost always unilateral causing orbital asymmetry. • It is characterized by hypoplasia of greater wing of sphenoid bone with enlargement of the middle cranial fossa. • Herniation of dura, CSF spaces or anterior temporal lobe into posterior aspect of orbit and anterior temporal arachnoid cysts are often seen. • Bare orbit sign is a classical radiographic finding of NF1. • It describes the absence of innominate line on the frontal radiograph of the skull, which is formed by the greater wing of sphenoid bone.
  • 49.
    CNS manifestations Neoplastic lesions: •Optic pathway glioma (OPG) • Nonoptic gliomas
  • 50.
    Optic pathway glioma(OPG) • OPG is the most common CNS neoplasm in paediatric patients. • The presence of bilateral optic nerve gliomas (ONG) is considered pathognomonic for NF1.N The main radiologic criteria to diagnose ONG are • Thickened optic nerve(>3.9 mm ) • With or without prominence of perioptic CSF spaces. • They show interrupted ‘dotted i’ appearance on axial images • Beanshaped kinky appearance in coronal images . • The optic canal may be widened with bony remodelling and scalloping. • The lesions may extend along optic pathway to the optic chiasm, the optic tracts and optic radiations.
  • 52.
    Nonoptic gliomas : •They are commonly seen in cerebellum, brainstem, tectal plate and basal ganglia regions. • The vast majority are low-grade gliomas mainly pilocytic astrocytomas;
  • 53.
    Benign nonneoplastic lesions Fociof altered signal intensity(FASI’s or UBO’s) : • Hamartomatous lesions of white matter, involve basal ganglia, thalami, dentate nuclei, cerebellar peduncles, optic radiations and brainstem in children and adolescents. • Represent regions of myelin vacuolization. • They are hyperintense on T2 sequences and typically iso- to mildly hyperintense on T1 images. • They do not show mass effect or enhancement unlike low- grade gliomas which show mass effect and sometimes enhancement.
  • 55.
    Cardiac and vascularmanifestations • NF1 vasculopathy is one of the leading causes of death in NF1 patients. • Renal artery stenosis with renovascular hypertension is the most frequent presentation, usually in the second decade of life. • Aneurysms and stenoses of aortic, renal, mesenteric and intracranial vasculature - younger patients. • Degenerative atherosclerotic aneurysm of the aorta - older patients. • Abnormalities of cerebral vasculature –”moyamoya” pattern.
  • 56.
    Thoracic manifestations • Neurofibromasat different locations • Interstitial lung disease, late onset complication - cysts or bullae - upper lobe - diffuse ground-glass opacities with mosaic pattern and bibasilar reticular opacities. • Neurofibromas involving trachea and oesophagus have also been reported.
  • 58.
    Abdominal manifestations • Broadspectrum of benign and malignant neoplasms. • Most frequent – neurofibroma , plexiform type . • Location - Paraspinal and presacral region , mesentery, gastrointestinal tract, liver and biliary tract, urinary bladder. • In GIT - GISTs are most common , multifocal , small bowel.
  • 62.
    Breast manifestations • Multiplesubcutaneous neurofibromas in periareolarregion. • On mammo- multiple, circumscribed and may be surrounded by a rim of air owing to their superficial nature. • On USG- similar to fibroadenomas in the subcutaneous plane. • NF1 is also associated with an increased risk of breast cancer development.
  • 63.
    Orbital manifestations • Orbital–periorbitalplexiform neurofibroma (OPPN) - Plexiform neurofibroma involving the orbit, eyelid, periorbital and facial structures and usually arise from the trigeminal nerve. • It is associated with sphenoid wing dysplasia on the same side. • OPPN is seen as poorly defined infiltrative lesion of the orbit and may extend to involve face and cranium.
  • 67.
    Neurofibromatosis 2 • Lesscommon than NF1. • Characterized by multiple cranial nerve schwannomas, meningiomas and spinal tumours. • It is considered synonymous with bilateral acoustic schwannomas.
  • 69.
    GENETICS: • Autosomal dominantinheritance. • Chr.22 • NF2 gene • Merlin protien(regulates growth of schwann cells and arachnoid cap cells)
  • 70.
    Clinical manifestations: • Hearingloss, tinnitus, headache followed by diplopia, vertigo, dizziness, imbalance and facial weakness. • Other presentations are neuropathies, scoliosis, paraplegia or neck pain, extremity weakness and cataract.
  • 71.
    Cutaneous manifestations: • CALMs– Few , no freckles. • Cutaneous schwannomas – slightly raised , plaque like , pigmented lesions.
  • 72.
    Central nervous system: •Cranial nerve schwannomas- 8th nerve ,MC. • Meningiomas • Meningioangiomatosis. • Glial hamartomas.
  • 73.
    Schwannomas: The characteristic imagingfeatures include • well-defined, encapsulated lesions • with or without cystic degeneration and haemorrhage. • well-circumscribed margins. • Smooth expansion of osseous foramina, osseous remodelling . • Deformation of adjacent brain parenchymal tissue. • Various degrees of solid nodular enhancement with internal cystic degeneration.
  • 74.
    • T1W :Isointense to muscle. • T2W : Heterogenously hyperintense. • T1+C : Heterogenous moderate to intense enhancement (cystic / necrotic areas)
  • 75.
    Meningiomas. • Meningiomas aresecond most common type of lesions in neurofibromatosis 2. • Meningiomas can be seen in the cranial and spinal regions. • Meningioma in first decade of life is highly suspicious of NF2.
  • 76.
    Spinal tumours: • IM- Ependymomas are the most common. These tumours cause focal cord enlargement and may be associated with proximal syrinx. • IDEM - Schwannomas of exiting nerve roots, spinal meningiomas. • MISME, which constitute multiple inherited schwannomas, meningiomas and ependymomas.
  • 80.
    Ophthalmic manifestations: • Opticnerve sheath meningioma. • Juvenile posterior subcapsular cataract. • Retinal hamartomas.
  • 81.
    Optic nerve sheathmeningioma: • Sporadic (adults), NF2 associated(children). • Arise from arachnoid cap cells of optic sheath. • Visual loss – due to compression on optic nerve. • Axial MRI – Tramtrack sign , Coronal MRI – Doughnut sign. • Calcifications +. • Hyperostosis of adjacent bones may be seen.
  • 83.
    SCHWANNOMATOSIS • Multiple schwannomaswithout vestibular or cutaneous schwannomas. • Mutation in LZTR1 and SMARCB1 gene on Chr.22. • Pain is most common symptom. • >3rd – 6th decade .
  • 84.
    Sturge–Weber syndrome • Sturge–Webersyndrome (SWS) is also known as encephalo-trigeminal angiomatosis. • Vascular and cutaneous features predominate without neoplasms.
  • 85.
    Genetics: • Sporadic mutationof GNAQ gene located on Chr.9q21. • Lack of maturation of primordial thin walled vessels Abnormal capillary and venous channels seen over leptomeninges , face , eye as Angiomas longstanding – venous ischemia.
  • 86.
    Clinical presentation: • Seizuresin infancy • Glaucoma. • Hemiparesis • Hormonal deficiencies,other vascular malformations are also known in SWS.
  • 87.
    Neuroimaging in Sturge–Webersyndrome On CT scan- dystrophic cortical and subcortical calcifications - tram track gyriform calcification. -U/L – 80%. -MC location – parietooccipital region.
  • 88.
    • Focal cerebralatrophy . • Thickened skull vault. • Ipsilateral choroid plexus enlargment. • Ipsilateral PNS and mastoid air cells dilated.
  • 89.
    MRI: • Ipsilateral cerebralatrophy. • Enlargement of subarchnoid spaces. • Calcifications – T2 – Hypo, GRE – blooming. • T1+C – intense leptomeningeal enhancement. • MRS – Reduced NAA.
  • 91.
    OPTHALMIC MANIFESTATIONS: • Choroidangiomas – Crescentric thickening of posterior wall of globe. • T1 : Hyper , T2 : Iso , T1+C : Intense enhancement. • Glaucoma. • Visual disturbance. • Buphthalmos.
  • 92.
    Cutaneous manifestations: • Portwine stain – capillary vascular malformation in face along the divisions of trigeminal nerve (ophthalmic division is most commonly involved – fore head and upper eye lid). • Focal soft tissue mass in skin and subcutaneous plane. CT : Iso – hypo to muscle. T1W : Iso – hypo T2W : Hyper Post contrast – intense enhancement.
  • 94.
    DD’s: • Acquired meningealprocesses – Meningitis , tumour spread , hemorrhage. • Meningioangiomatosis – It is rare meningovascular hamartomatous plaque like mass .No PWS. • Klippel–trenaunay–webersynd : pial angiomas present associated soft tissue and bone hypertrophy. • PHACES syndrome(posterior fossa malformations , infantile hemangiomas , arterial anamolies , coarctation of aorta , cardiac , eye and sternal anamolies ).
  • 96.
  • 97.
    • Tommorow casepresentations by Dr . Reshma (HRCT temporal bone anatomy) and Dr . Avani (Pylonephritis)